WELLCOME U3B (Tabloid 40 mg)
Generic Name: thioguanine
Pill imprint WELLCOME U3B has been identified as Tabloid 40 mg.
Tabloid is used in the treatment of acute nonlymphocytic leukemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Tabloid 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Tabloid (thioguanine)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.